Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/22618

Title: Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach
Authors: Weiss, Jason T.
Dawson, John C.
Macleod, Kenneth G.
Rybski, Witold
Fraser, Craig
Torres-Sanchez, Carmen
Patton, E. Elizabeth
Bradley, Mark
Carragher, Neil O.
Unciti-Broceta, Asier
Keywords: Bioorthogonal chemistry
Pharmaceuticals
Medicine
Issue Date: 2014
Publisher: © Macmillan
Citation: WEISS, J. ... et al., 2014. Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach. Nature Communications, 5, doi: 10.1038/ncomms4277.
Abstract: A bioorthogonal organometallic reaction is a biocompatible transformation undergone by a synthetic material exclusively through the mediation of a non-biotic metal source; a selective process used to label biomolecules and activate probes in biological environs. Here we report the in vitro bioorthogonal generation of 5-fluorouracil from a biologically inert precursor by heterogeneous Pd0 catalysis. Although independently harmless, combined treatment of 5-fluoro-1-propargyl-uracil and Pd0-functionalized resins exhibits comparable antiproliferative properties to the unmodified drug in colorectal and pancreatic cancer cells. Live-cell imaging and immunoassay studies demonstrate that the cytotoxic activity of the prodrug/Pd0-resin combination is due to the in situ generation of 5-fluorouracil. Pd0-resins can be carefully implanted in the yolk sac of zebrafish embryos and display excellent biocompatibility and local catalytic activity. The in vitro efficacy shown by this masking/activation strategy underlines its potential to develop a bioorthogonally activated prodrug approach and supports further in vivo investigations.
Sponsor: J.T.W. thanks the College of Medicine and Veterinary Medicine and the University of Edinburgh for a Darwin International Scholarship and an Edinburgh Global Research Scholarship. N.O.C. and A.U.-B. thank RCUK and IGMM, respectively, for an Academic Fellowship. We are grateful to the Edinburgh Cancer Research UK Centre for funding this research through the CRUK Development Fund. E.E.P., C.F. and W.R. are funded by the MRC.
Version: Published
DOI: 10.1038/ncomms4277
URI: https://dspace.lboro.ac.uk/2134/22618
Publisher Link: http://dx.doi.org/10.1038/ncomms4277
Appears in Collections:Published Articles (Mechanical, Electrical and Manufacturing Engineering)

Files associated with this item:

File Description SizeFormat
Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach.pdfPublished version2.09 MBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.